13 Patents
- US125401792026Compositions and Methods for Treating Cancer with Anti-ror1 Immunotherapy
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US124537802025Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US123919582025Compositions and Methods for Treating Cancer with Anti-cd38 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US123714902025Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites - 0 cites
- 0 cites
- US121228312024Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites - US120374032024Compositions and Methods for Treating Cancer with Anti-cd123 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US118780522024Compositions and Methods for Treating Cancer with Anti-cd22 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US118076822023M971 Chimeric Antigen Receptors
The United States Of America, As Represented By The Secretary, Department Of Heath And Human Services
0 cites - 0 cites
- US117084082023Compositions and Methods for Treating Cancer with Anti-cd19 Immunotherapy
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services
0 cites - US116801032023Compositions and Methods for Treating Cancer with Anti-cd19/cd20 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites